Netcare (NTC)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 1,728.00 |
|---|---|
| 52-week range | 1,412.00 – 1,942.00 |
| Return, 1 month / 3 months | −3.2% / −5.7% |
| Return, 1 year / 3 years | +18.1% / +33.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 22.1% |
| Worst drawdown (1 year) | -10.9% |
| Average daily value traded | 6,738.04M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Netcare is a South African private healthcare group that runs acute care hospitals and a network of primary care and dental clinics, along with emergency medical services and ambulance operations. It serves patients who pay through medical schemes, private insurance or out of pocket, and it also works with public sector referrals. The company is based in Johannesburg and provides hospital care, specialist services and related healthcare support across South Africa.
On this site Netcare appears as a stock on the Johannesburg Exchange (South Africa), code NTC, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Netcare (NTC) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 1,728.00 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 31 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.1% and over the last three months it fell 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -10.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.7% | ||
| 6-month return | -1.3% | ||
| 12-month return, skipping the last month | 22.0% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.9% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 6,738.04M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −3.2% |
| 3 months | −5.7% |
| 6 months | −1.3% |
| 1 year | +18.1% |
| 3 years | +33.3% |
| 5 years | +16.2% |
Signals
| 50-day / 200-day average | 1,787.74 / 1,725.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 35.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jul 2023 | ZAC 30.0000 |
| 25 Jan 2023 | ZAC 30.0000 |
| 6 Jul 2022 | ZAC 20.0000 |
| 26 Jan 2022 | ZAC 34.0000 |
| 22 Jan 2020 | ZAC 64.0000 |
| 3 Jul 2019 | ZAC 47.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.